BOLT vs REG · rev $7.7M vs P/E 34, $12.93B cap
Bolt Biotherapeutics (BOLT) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
REG does not have a complete income-statement cache yet.
BOLT currently screens at market cap $11.3M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the BOLT and REG stock pages for the full models.
Not investment advice.